Roundhill GLP-1 & Weight Loss ETF
OZEM
#2894
ETF rank
โ‚ฌ41.1 M
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
26,01ย โ‚ฌ
Share price
0.97%
Change (1 day)
13.43%
Change (1 year)
Roundhill GLP-1 & Weight Loss ETF (OZEM) provides exposure to companies developing innovative GLP-1 and other weight loss therapies.

Roundhill GLP-1 & Weight Loss ETF - Holdings

Etf holdings as of June 3, 2026Number of holdings: 28

Full holdings list

Weight %NameTickerShares Held
18.38%
Eli Lilly & CoLLY8247
12.98%
Novo Nordisk A/SNVO144433
6.56%
Pfizer IncPFE122599
4.77%
CSPC Pharmaceutical Group Ltd1093 HK2360000
4.59%
Kailera Therapeutics IncKLRA96982
4.51%
Viking Therapeutics IncVKTX73536
4.32%
Hanmi Pharm Co Ltd128940 KS6165
4.32%
Chugai Pharmaceutical Co Ltd4519 JP43300
4.07%
Zealand Pharma A/SZEAL DC40944
3.97%
Innovent Biologics Inc1801 HK188500
3.62%
Amgen IncAMGN5269
3.30%
AstraZeneca PLCAZN8878
2.82%
Roche Holding AGROP SW3413
2.58%
United Laboratories International Holdings Ltd/The3933 HK1066000
2.55%
Structure Therapeutics IncGPCR32719
2.53%
Regeneron Pharmaceuticals IncREGN2001
2.49%
Ascletis Pharma Inc1672 HK901000
2.15%
Gubra A/SGUBRA DC19705
2.11%
MBX Biosciences IncMBX32770
1.75%
Biohaven LtdBHVN82409
1.70%
Gilead Sciences IncGILD6376
1.48%
Rhythm Pharmaceuticals IncRYTM8394
1.16%
Shionogi & Co Ltd4507 JP31400
0.71%
WaVe Life Sciences LtdWVE59425
0.59%
First American Government Obligations Fund 12/01/2031FGXXX280448.13
0.33%
Cash & OtherCash&Other159043.87
0.24%
Corbus Pharmaceuticals Holdings IncCRBP15307
-0.57%
SWISS FRANCCHF-215321.29